Toutes les études
Pas encore en recrutementPHASE3INTERVENTIONNEL

Optimizing the Use of Aspirin for the Prevention of Preeclampsia

This study is investigating if pregnant women who are at a higher risk of developing a condition called pre-eclampsia can safely stop taking low-dose aspirin earlier in their pregnancy. Currently, many high-risk women take aspirin until close to their due date. Aspirin helps prevent pre-eclampsia by supporting the baby's development in early pregnancy. It's not clear if continuing aspirin into later pregnancy offers extra benefits. This study hopes to find out if stopping aspirin between 24 and 28 weeks of pregnancy is just as effective as continuing until 36 weeks. It will also look at whether this is true for women from different backgrounds, including those of African origin where pre-eclampsia is more common.

En un coup d'œil

Statut
Pas encore en recrutement
Phase
PHASE3
Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Objectif d'inscription
15,160
Démarrer
01 juil. 2026
Achèvement estimé
01 May 2028

De quoi parle cette étude ?

When you're pregnant, a small number of women might develop a condition called pre-eclampsia. This can lead to high blood pressure and other problems for both mum and baby. To help prevent this, doctors sometimes recommend that pregnant women who are at a higher risk take a low dose of aspirin every day.

At the moment, women identified as high-risk typically take aspirin from early pregnancy until about 36 weeks. We know that aspirin mainly helps during the first half of pregnancy by helping the placenta (the organ that provides food and oxygen to the baby) to develop well. However, it's not clear if continuing to take aspirin after around 24 to 28 weeks of pregnancy offers any extra protection. Many women who take aspirin because they're thought to be at high risk for pre-eclampsia might not actually develop the condition. This means they could be taking aspirin for longer than needed, and like any medicine, aspirin can have side effects, such as a slightly increased risk of bleeding.

This study aims to discover if it's safe and effective for high-risk pregnant women to stop taking aspirin earlier, specifically between 24 and 28 weeks, compared to the usual practice of continuing until 36 weeks. Researchers will collect information from many women across different countries to understand if the shorter treatment is just as good at preventing pre-eclampsia. This is particularly important for a wide range of women, including those of African descent, who may have a higher natural risk of pre-eclampsia. The results could help doctors decide on the best and safest aspirin treatment plans for pregnant women in the future.

Points clés

  • Study looks at safer, shorter aspirin use for pre-eclampsia.
  • Compares stopping aspirin at 24-28 weeks vs. 36 weeks.
  • Aims to see if earlier stopping is just as effective.
  • Helps understand aspirin use for diverse groups, including African women.
  • You might have extra tests if you participate.
  • Vous pouvez arrêter de participer à tout moment.

Qui peut être éligible ?

This study is looking for pregnant women who are at least 18 years old. You must be expecting one baby (not twins or more) and be able to understand the study information.

To be eligible, you would have already had a special screening test in your first trimester (between 11 and 14 weeks) that showed you are at a higher risk for pre-eclampsia. You should also already be taking a daily low dose of aspirin (150 mg) because of this high-risk result. You need to be willing to sign a consent form, agree to follow all study instructions, and be happy with your assigned treatment plan (either stopping aspirin early or continuing it longer). This might involve having some extra blood tests and ultrasound scans.

However, you won't be able to join if you've sadly experienced serious pregnancy complications early on, or if your baby has known serious health problems. Also, if you're allergic to aspirin, or have any other medical conditions that mean stopping aspirin would be unsafe for you (for example, if you need aspirin for a heart condition), then this study wouldn't be suitable.

Cet étude pourrait-elle vous convenir ?

Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.

  1. Are you 18 years or older and currently pregnant with one baby?
  2. Did your first-trimester screening show you're at high risk for pre-eclampsia?
  3. Are you currently taking 150 mg of aspirin daily for this reason?
  4. Do you have any known allergies to aspirin or other medical conditions that mean you can't stop taking it?
  5. Are you willing to have additional tests and follow the study's assigned treatment plan?
Répondez à chaque question pour voir votre résultat.

En quoi consiste la participation ?

If you join this study, you'll be randomly put into one of two groups, like flipping a coin. One group will be asked to stop taking your daily low-dose aspirin (150 mg) when you are between 24 and 28 weeks pregnant. The other group will continue taking your low-dose aspirin every day until you are 36 weeks pregnant. You won't know which group you're in until it's decided.

During the study, you'll continue with your regular antenatal appointments. You might also be asked to have some additional blood tests and ultrasound scans at certain times throughout your pregnancy. Researchers will keep track of your health and your baby's health to see how you both are doing. The study will continue until after your baby is born, and researchers will follow up on any health events for both you and your baby. The total duration of your active participation will be from the time you join until after your baby is born, likely a few weeks post-delivery.

Risques et avantages potentiels

Taking part in this study may offer some benefits, such as contributing to new knowledge that could help future pregnant women. If you are in the group that stops aspirin earlier, you might avoid potential side effects of prolonged aspirin use, including a small risk of bleeding. The main risk involved is that if stopping aspirin early is found to be less effective, you could potentially have a slightly increased risk of developing pre-eclampsia compared to continuing it longer. However, the study is designed to carefully monitor all participants for their safety, and a similar study among mainly European women suggested that stopping early was just as safe. Remember, your participation is completely voluntary; you can choose to leave the study at any time, for any reason, without it affecting your medical care.

Locations (38)

  • Medical University of Vienna
    Code postal vérifié
    Vienne, Autriche
  • St Josef Hospital
    Code postal vérifié
    Vienne, Autriche
  • Dr Shterev Hospital
    Code postal vérifié
    Sofia, Bulgaria
  • Saint Patrick Hospital
    Code postal vérifié
    Ofinso, Ghana
  • Holy Family Hospital
    Code postal vérifié
    Techiman, Ghana
  • Hopital Phillipe Senghor
    Code postal vérifié
    Dakar, Senegal
  • Centre Hospitalier Régional de Saint-Louis
    Code postal vérifié
    Saint-Louis, Senegal
  • Hospital San Cecilio
    Code postal vérifié
    Granada, Spain
  • Hospital Universitari Dexeus
    Code postal vérifié
    Barcelona, Spain
  • Hospital Dr.Josep Trueta
    Code postal vérifié
    Girona, Spain
  • Hospital Joan XXIII
    Code postal vérifié
    Tarragona, Spain
  • Hospital de Cruces
    Code postal vérifié
    Barakaldo, Spain

Questions fréquentes

What is pre-eclampsia?

Pre-eclampsia is a condition that can happen in pregnancy, causing high blood pressure and other problems for the mother and baby, usually after 20 weeks.

Why is aspirin used for pre-eclampsia?

Low-dose aspirin can help prevent pre-eclampsia by improving how the placenta (your baby's life support) develops in early pregnancy.

Will I know which treatment group I'm in?

Yes, once you're assigned to a group (either stopping aspirin early or continuing it), you will know which plan you are following.

Are there any extra doctor visits required?

You'll have your usual antenatal checks, but might have a few extra blood tests and ultrasound scans specific to the study.

What if I take aspirin for another medical condition?

If you need aspirin for other medical reasons, this study would likely not be suitable for you as stopping it could be unsafe.

Comment en savoir plus

Manel Mendoza Cobaleda, Professor

Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.

Intéressé à participer ?

Inscrivez votre intérêt

Partagez vos coordonnées et l'équipe de recherche pour "Optimizing the Use of Aspirin for the Prevention of Preeclam… vous contactera si vous êtes éligible. Consultez toujours votre médecin avant d'accepter de participer.

Discussion

Discussion communautaire

Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.